Portsmouth, NH: Today, ActivMed Practices & Research, Inc., a private clinical research site, announced that they have joined a clinical trial to examine the safety and efficacy of a vaccine for the prevention of COVID-19 in adults. The trial’s Principal Investigator is Michael J. McCartney, M.D., ActivMed’ s Chief Medical Director, and will be conducted in the Portsmouth, NH location.
ActivMed is wrapping up a clinical trial for a COVID-19 antibody test and is now joining this Phase III study for a potential vaccine. Study participants must be at least 18 years old, in good general health, and no previous positive COVID-19 test results.
Currently, there are no specific treatments available against COVID-19 and accelerated vaccine development is urgently needed. A safe and effective vaccine for COVID-19 prevention would have significant public health impact.
“Our team at ActivMed looks forward to help bring a vaccine against COVID-19 and a hopeful end to the pandemic.” says Dr. McCartney about this opportunity. He goes on to say “We hope you will help, as we are looking for trial participants. We are trying to provide as safe an environment as possible. We are following CDC recommendations for participant safety. It is through this collaboration that we will be able to conduct this monumental endeavor. Looking forward to seeing you in our Portsmouth, N.H. site!”
Preliminary studies show promising results. The vaccine is not approved in the United States and requires further testing before presenting data for approval by the FDA. The study will be conducted in approximately 100 sites across the U.S. and looks to enroll 30, 000 total participants. The study is sponsored by AstraZeneca.
About ActivMed Practices & Research, Inc.: ActivMed is a clinical research network with 4 locations, based in Methuen, MA. Founded in 1994, ActivMed has conducted over 800 clinical trials, offering the same trials that are available in Boston hospitals without the hassle of travel and parking. ActivMed was voted One of the Top 25 places to Work North of Boston for 2014 by North of Boston Business Magazine.